Caffeine-potentiated chemotherapy for metastatic osteosarcoma
โ Scribed by Hiroaki Kimura; Hiroyuki Tsuchiya; Toshiharu Shirai; Hideji Nishida; Katsuhiro Hayashi; Akihiko Takeuchi; Issei Ohnari; Katsuro Tomita
- Publisher
- Springer Japan
- Year
- 2009
- Tongue
- English
- Weight
- 311 KB
- Volume
- 14
- Category
- Article
- ISSN
- 0949-2658
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract A C3H murine osteosarcoma was used to investigate the effects of surgical adjuvant chemotherapy and to establish the relationship between primary tumor size and the number of metastatic lung tumor foci. The transplanted primary tumor was allowed to grow for 28 or 33 days and the lungs w
## Background: Since the first trial for chemotherapy in children with osteosarcoma in 1977, the survival rate has gradually improved. currently, more than 60% of all patients are cured, mainly because of the introduction of intensive chemotherapy using doxorubicin, high dose methotrexate, and cisp